市場調査レポート

商品コード

1701490

3Dバイオプリンティングの市場規模、シェア、成長分析、コンポーネント別、材料別、用途別、エンドユーザー別、地域別 - 産業予測 2025-2032年

3D Bioprinting Market Size, Share, and Growth Analysis, By Component (3D Bioprinters, Bioinks), By Material (Living Cells, Hydrogels), By Application, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年04月01日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 774,224円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 905,696円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,037,168円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

3Dバイオプリンティング 2023年の市場規模は23億米ドルで、2024年の25億8,000万米ドルから2032年には65億3,000万米ドルに拡大し、予測期間（2025-2032年）のCAGRは12.3％で成長する見通しです。

市場拡大の主な要因は、慢性呼吸器疾患に直面している高齢化人口と、進行中の臓器ドナー不足です。技術の進歩とともに研究開発への投資が増加することで、予測期間を通じて成長がさらに促進されます。3Dプリンティング技術の台頭は、特に移植用の心臓、腎臓、肺のような複雑な固形臓器の作成において、医療分野での重要性を増しています。3Dバイオプリンティングは、個々の患者のニーズに合わせた臓器や組織構造の精密なカスタマイズを可能にし、専門的な医療処置や移植を強化します。この技術革新は、臓器不足の問題に取り組むと同時に、複雑な疾患の管理に効果的なソリューションを提供します。その結果、個別化された患者ケアに対する需要の高まりが、高性能バイオプリンター市場を大きく牽引しています。

市場概要
3Dバイオプリンター
- マイクロ押し出しバイオプリンター
- インクジェット3Dバイオプリンター
- レーザー支援バイオプリンター
- 光造形法バイオプリンター
- 磁気式3Dバイオプリンター
- その他の3Dバイオプリンター
バイオインク
- 天然バイオインク
- ハイブリッドバイオインク
- 合成バイオインク
ソフトウェア
消耗品

3Dバイオプリンティング市場規模：材料別& CAGR（2025-2032）

市場概要
生きた細胞
ハイドロゲル
細胞外マトリックス
その他の材料

3Dバイオプリンティング市場規模：用途別& CAGR（2025-2032）

市場概要
調査アプリケーション
- 薬物調査
- 再生医療
- 3D細胞培養
臨床応用
- 肌
- 骨と軟骨
- 血管
- その他の臨床応用

3Dバイオプリンティング市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
学術調査機関
製薬・バイオテクノロジー企業
病院

3Dバイオプリンティング市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Merck KGaA（Germany）
Poietis SAS（France）
BICO Group AB（Sweden）
Tissuelabs（Canada）
Materialise NV（Belgium）
3D Biotek, LLC（United States）
Microdrop Technologies GmbH（Germany）
REGEMAT 3D, SL（Spain）
MEDPRIN（China）
PRODWAYS（France）
Stratasys Ltd.（United States & Israel）
Organovo Holdings, Inc.（United States）
CELLINK AB（Sweden）

結論と提言

Product Code: SQMIG20I2072

3D Bioprinting Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.58 billion in 2024 to USD 6.53 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

Market expansion is primarily fueled by the aging population facing chronic respiratory disorders and the ongoing organ donor shortage. Increased investment in research and development, alongside technological advancements, is set to further propel growth throughout the forecast period. The rise of 3D printing technology, particularly in creating complex solid organs like hearts, kidneys, and lungs for transplantation, is becoming increasingly crucial within the medical field. 3D bioprinting enables the precise customization of organ and tissue structures tailored to individual patient needs, enhancing specialized medical procedures and transplants. This innovation addresses the organ scarcity issue while providing effective solutions for managing complex diseases. Consequently, the heightened demand for personalized patient care is significantly driving the market for high-performance bioprinters.

Top-down and bottom-up approaches were used to estimate and validate the size of the 3D Bioprinting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

3D Bioprinting Market Segments Analysis

Global 3D Bioprinting Market is segmented by Component, Material, Application, End User and region. Based on Component, the market is segmented into 3D Bioprinters, Bioinks, Software and Consumables. Based on Material, the market is segmented into Living Cells, Hydrogels, Extracellular Matrices and Other Materials. Based on Application, the market is segmented into Research Applications and Clinical Applications. Based on End User, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the 3D Bioprinting Market

The 3D bioprinting market is driven by the increasing adoption of this innovative technology by pharmaceutical companies, which enables rapid development and identification of novel pharmaceuticals. By utilizing 3D bioprinted tissues, drug testing becomes more efficient, secure, and cost-effective compared to traditional methods. This cutting-edge approach allows pharmaceutical firms to conduct crucial medicine assessments within hours, significantly shortening the typical new drug development timeline of three to six years. Furthermore, R&D teams can leverage 3D bioprinting for early and preclinical testing, leading to reduced reliance on animal testing, enhanced production capabilities, and accelerated drug development processes, thereby transforming the pharmaceutical landscape.

Restraints in the 3D Bioprinting Market

The 3D Bioprinting market faces significant restraints primarily due to the challenges encountered by various research organizations and medical institutions in adopting and implementing these technologies. The high costs associated with the specialized machinery and bioinks required for fabricating functional tissues and organs play a crucial role in hindering widespread adoption. Furthermore, the complexity of the procedures necessitates intricate protocols and the expertise of skilled personnel, which not only escalates operational costs but also restricts the potential for these advanced treatments to gain universal acceptance. Consequently, these factors create barriers to the effective integration of 3D bioprinting in healthcare settings.

Market Trends of the 3D Bioprinting Market

The 3D bioprinting market is witnessing a significant trend characterized by an increasing number of strategic alliances among research organizations, biotechnology firms, and academic institutions. These collaborations are accelerating the development of innovative bioprinting technologies through enhanced knowledge sharing and resource pooling. The synergy created through these partnerships facilitates groundbreaking advancements, propelling the market forward. As key players leverage collective expertise and capabilities, we can expect a surge in applications within regenerative medicine, tissue engineering, and pharmaceutical testing, ultimately driving robust growth and expanding the scope of 3D bioprinting solutions in the healthcare sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Technology Analysis

Global 3D Bioprinting Market Size by Component & CAGR (2025-2032)

Market Overview
3D Bioprinters
- Micro Extrusion Bioprinters
- Inkjet 3D Bioprinters
- Laser-Assisted Bioprinters
- Stereolithography-Based Bioprinters
- Magnetic 3D Bioprinters
- Other 3D Bioprinters
Bioinks
- Natural Bioinks
- Hybrid Bioinks
- Synthetic Bioinks
Software
Consumables

Global 3D Bioprinting Market Size by Material & CAGR (2025-2032)

Market Overview
Living Cells
Hydrogels
Extracellular Matrices
Other Materials

Global 3D Bioprinting Market Size by Application & CAGR (2025-2032)

Market Overview
Research Applications
- Drug Research
- Regenerative Medicine
- 3d Cell Culture
Clinical Applications
- Skin
- Bone & Cartilage
- Blood Vessels
- Other Clinical Applications

Global 3D Bioprinting Market Size by End User & CAGR (2025-2032)

Market Overview
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals

Global 3D Bioprinting Market Size & CAGR (2025-2032)

North America (Component, Material, Application, End User)
- US
- Canada
Europe (Component, Material, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Component, Material, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Component, Material, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Component, Material, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Poietis SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BICO Group AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissuelabs (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Materialise NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3D Biotek, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microdrop Technologies GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
REGEMAT 3D, SL (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MEDPRIN (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRODWAYS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stratasys Ltd. (United States & Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organovo Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CELLINK AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments